HPV (+) N = 22 | HPV (-) N = 5 | p | |
---|---|---|---|
Gender | 0.1751a | ||
Female | 17 | 3 | |
Male | 05 | 2 | |
Site of primary tumor | 0.2386a | ||
Anal Margin | 3 | - | |
Anal Canal | 15 | 5 | |
Anal Margin and Canal | 3 | 3 | |
Lesion type | 0.7809a | ||
Ulceration | 3 | 1 | |
Vegetating | 2 | - | |
Ulceration and Vegetating | 5 | 1 | |
Stenosing | 1 | - | |
Non evaluated | 10 | 06 | |
Size of the lesion (cm) | 0.3657a | ||
≤ 0.5 | - | 1 | |
0.6–2.0 | 6 | 2 | |
2.1–5.0 | 11 | 4 | |
≥ 5.1 | 03 | - | |
UJCC/TNM Staging | 0.7542a | ||
I | - | 1 | |
II | 2 | - | |
III | 9 | - | |
IV | - | - | |
Non evaluated | 9 | 6 | |
Lymph node involvement | 0.3133* | ||
Yes | 7 | - | |
No | 11 | 5 | |
Non evaluated | 2 | 2 | |
Inflammatory process | 0.3017a | ||
Yes | 3 | 2 | |
No | 12 | 2 | |
Non evaluated | 6 | 4 |